Tempest Therapeutics annual operating expenses
2012
2013
2014
2015
2016
2017
2022
2023
2024
2025
Tempest Therapeutics Operating Expenses Growth & History (TPST)
Tempest Therapeutics's operating expenses was $26.6M for fiscal 2025.
View full Tempest Therapeutics company overviewTempest Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $26.6M | −$15.5M | −36.77% |
| 2024 | 2024-12-31 | $42.0M | $12.9M | +44.14% |
| 2023 | 2023-12-31 | $29.2M | −$5.5M | −15.83% |
| 2022 | 2022-12-31 | $34.6M | — | — |
| 2017 | 2017-12-31 | $50.9M | −$30.8M | −37.67% |
| 2016 | 2016-12-31 | $81.7M | $9.4M | +12.99% |
| 2015 | 2015-12-31 | $72.3M | $24.3M | +50.79% |
| 2014 | 2014-12-31 | $47.9M | $18.8M | +64.53% |
| 2013 | 2013-12-31 | $29.1M | $15.6M | +115.34% |
| 2012 | 2012-12-31 | $13.5M | — | — |
Tempest Therapeutics quarterly operating expenses
Q2.12
Q3.12
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.3M | −$2.7M | −34.09% |
| Q1 2026 | 2026-03-31 | $5.5M | −$5.4M | −49.35% |
| Q4 2025 | 2025-12-31 | $4.1M | — | — |
| Q3 2025 | 2025-09-30 | $3.6M | — | — |
| Q2 2025 | 2025-06-30 | $8.0M | — | — |
| Q1 2025 | 2025-03-31 | $10.9M | — | — |
| Q3 2018 | 2018-09-30 | $6.0M | −$3.5M | −37.09% |
| Q2 2018 | 2018-06-30 | $8.0M | −$10.0M | −55.67% |
| Q1 2018 | 2018-03-31 | $7.6M | −$7.0M | −47.79% |
| Q4 2017 | 2017-12-31 | $8.8M | −$13.7M | −60.98% |
| Q3 2017 | 2017-09-30 | $9.5M | −$9.7M | −50.62% |
| Q2 2017 | 2017-06-30 | $18.0M | −$416,000 | −2.26% |
| Q1 2017 | 2017-03-31 | $14.7M | −$6.9M | −32.13% |
| Q4 2016 | 2016-12-31 | $22.5M | $2.1M | +10.26% |
| Q3 2016 | 2016-09-30 | $19.2M | $1.3M | +7.36% |
| Q2 2016 | 2016-06-30 | $18.4M | $1.2M | +7.13% |
| Q1 2016 | 2016-03-31 | $21.6M | $4.8M | +28.27% |
| Q4 2015 | 2015-12-31 | $20.4M | $2.1M | +11.53% |
| Q3 2015 | 2015-09-30 | $17.8M | $5.4M | +43.94% |
| Q2 2015 | 2015-06-30 | $17.2M | $7.6M | +79.30% |
| Q1 2015 | 2015-03-31 | $16.8M | $9.2M | +119.97% |
| Q4 2014 | 2014-12-31 | $18.3M | $7.3M | +66.07% |
| Q3 2014 | 2014-09-30 | $12.4M | $5.5M | +79.05% |
| Q2 2014 | 2014-06-30 | $9.6M | $3.6M | +59.36% |
| Q1 2014 | 2014-03-31 | $7.7M | $2.5M | +47.83% |
| Q4 2013 | 2013-12-31 | $11.0M | $6.8M | +161.65% |
| Q3 2013 | 2013-09-30 | $6.9M | $3.8M | +121.96% |
| Q2 2013 | 2013-06-30 | $6.0M | $2.8M | +86.18% |
| Q1 2013 | 2013-03-31 | $5.2M | $2.2M | +74.48% |
| Q4 2012 | 2012-12-31 | $4.2M | — | — |
| Q3 2012 · Sep 30 | 2012-09-30 | $3.1M | $2.3M | +303.10% |
| Q2 2012 · Jun 30 | 2012-06-30 | $3.2M | $2.8M | +688.78% |
| Q1 2012 | 2012-03-31 | $3.0M | — | — |
| Q3 2012 · Sep 30 | 2011-09-30 | $774,000 | — | — |
| Q2 2012 · Jun 30 | 2011-06-30 | $410,000 | — | — |
Tempest Therapeutics operating expenses trends
Between the periods ended 2012-12-31 and 2025-12-31, Tempest Therapeutics's operating expenses increased from $13.5M to $26.6M, a change of $13.0M. The latest reported quarter, Q2 2026, shows $5.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tempest Therapeutics source filings ↗